Market Cap 29.53M
Revenue (ttm) 26.55M
Net Income (ttm) -91.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -345.46%
Debt to Equity Ratio -1.26
Volume 192,300
Avg Vol 120,576
Day's Range N/A - N/A
Shares Out 28.95M
Stochastic %K 65%
Beta 0.48
Analysts Sell
Price Target $6.00

Company Profile

Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degene...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 768 2170
Address:
170 Park Avenue, Florham Park, United States
luckydog2
luckydog2 Jun. 4 at 1:31 PM
$CELU @nosey could this be the reason Dr. Hariri was meeting with RFK?
1 · Reply
luckydog2
luckydog2 Jun. 4 at 12:03 PM
$CELU Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies https://www.globenewswire.com/news-release/2026/06/04/3306696/0/en/celularity-and-fountain-life-announce-availability-of-cenplacel-l-for-investigational-use-under-new-florida-law-establishing-scalable-pathway-for-advancement-of-placental-derived-c.html?_gl=1*llxv7e*_up*MQ..*_ga*NDUzMTIyMzA4LjE3ODA1NzQ0ODI.*_ga_B6167QB2TF*czE3ODA1NzQ0ODEkbzEkZzAkdDE3ODA1NzQ1MjkkajEyJGwwJGgzMDY4MTM5MTY.*_ga_ERWPGTJ5X8*czE3ODA1NzQ0ODEkbzEkZzAkdDE3ODA1NzQ1MjkkajEyJGwwJGgw
0 · Reply
Nosay
Nosay Jun. 4 at 10:16 AM
$CELU shareholder letter didn’t contain much. But I did appreciate that it said we can expect more future updates. I am hoping this is the start of the pump. No idea how high it will go. But the insiders own approx 75% and unlocked all of their shares in December and early Jan allowing them to sell on the open market. Their warrants repriced to 1.33 as well. Phil Barach has warrants at 1.66 and 2$. They need to raise more money at some point. They can easily drive this up much higher than that and exercise their warrants and sell for a profit. My bet is $8 ish. But we’ll see.
0 · Reply
focafoca99
focafoca99 Jun. 3 at 9:36 PM
$CELU promoted Rick Gonzalez to Chief Commercial Officer.
0 · Reply
KingStocks1
KingStocks1 Jun. 3 at 8:49 PM
$CELU piece of shit shareholder update form CEO. 5+ years of bullshit
0 · Reply
luckydog2
luckydog2 Jun. 3 at 8:33 PM
$CELU Dr. Hariri's letter to shareholders. https://www.reddit.com/r/CelularityNews/s/mrGN3bEeX3
0 · Reply
luckydog2
luckydog2 Jun. 3 at 12:15 PM
$CELU Celularity Appoints Rick Gonzalez as Chief Commercial Officer Appointment supports Celularity’s focus on longevity, regenerative medicine and preservation of human performance by advancing commercialization of cenplacel-L and Lifebank https://www.globenewswire.com/news-release/2026/06/03/3305991/0/en/celularity-appoints-rick-gonzalez-as-chief-commercial-officer.html?_gl=1*1fawbd*_up*MQ..*_ga*MTM4MTg4OTUyMy4xNzgwNDg4Nzg3*_ga_ERWPGTJ5X8*czE3ODA0ODg3ODckbzEkZzAkdDE3ODA0ODg3ODckajYwJGwwJGgw*_ga_B6167QB2TF*czE3ODA0ODg3ODckbzEkZzAkdDE3ODA0ODg3ODckajYwJGwwJGgxNTY3OTA1MTg4
0 · Reply
ToxicAvenger
ToxicAvenger Jun. 1 at 10:14 PM
$CELU almost boom time...
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Jun. 1 at 8:39 PM
$CELU Looks like shorts covering. Let go captain Harri
0 · Reply
Nosay
Nosay Jun. 1 at 6:34 PM
$IBRX $CELU if you would have listened to me this morning you’d be up 6% instead of down 4%. Should be a massive run up after filing Q1s regaining compliance and announcing the positive results seen from Fountain Life.
1 · Reply
Latest News on CELU
Celularity Releases CEO Letter to Shareholders

Jun 3, 2026, 4:15 PM EDT - 1 day ago

Celularity Releases CEO Letter to Shareholders


Celularity Receives Nasdaq Notice Regarding Form 10-Q

May 29, 2026, 5:15 PM EDT - 6 days ago

Celularity Receives Nasdaq Notice Regarding Form 10-Q


Celularity Annual report: Q4 2025

Apr 30, 2026, 7:00 AM EDT - 5 weeks ago

Celularity Annual report: Q4 2025


NEXGEL Appoints Ian Blackman as Chief Financial Officer

Apr 27, 2026, 9:00 AM EDT - 5 weeks ago

NEXGEL Appoints Ian Blackman as Chief Financial Officer


NexGel closes acquisition of products from Celularity

2026-04-21T15:06:20.000Z - 6 weeks ago

NexGel closes acquisition of products from Celularity

NXGL


Celularity announces closing of transaction with NexGel

2026-04-21T13:07:46.000Z - 6 weeks ago

Celularity announces closing of transaction with NexGel


Celularity Announces Closing of Transaction with NexGel

Apr 21, 2026, 8:30 AM EDT - 6 weeks ago

Celularity Announces Closing of Transaction with NexGel


Celularity secures $35M strategic license deal

2026-03-10T12:41:03.000Z - 3 months ago

Celularity secures $35M strategic license deal


Celularity Registration statement: Registration Filing

Dec 31, 2025, 7:00 AM EST - 5 months ago

Celularity Registration statement: Registration Filing


Celularity Announces Closing of Financing Transactions

Dec 22, 2025, 4:01 PM EST - 5 months ago

Celularity Announces Closing of Financing Transactions


Celularity Registration statement: Registration Filing

Dec 19, 2025, 7:00 AM EST - 5 months ago

Celularity Registration statement: Registration Filing


Celularity announces up to $12M of capital from Philip Barach

2025-12-18T19:15:11.000Z - 6 months ago

Celularity announces up to $12M of capital from Philip Barach


Celularity Quarterly report: Q3 2025

Nov 14, 2025, 7:00 AM EST - 7 months ago

Celularity Quarterly report: Q3 2025


Celularity Proxy statement: Proxy Filing

Nov 7, 2025, 7:00 AM EST - 7 months ago

Celularity Proxy statement: Proxy Filing


Celularity Proxy statement: Proxy Filing

Nov 7, 2025, 7:00 AM EST - 7 months ago

Celularity Proxy statement: Proxy Filing


Celularity announces publication of Phase 2 study on PDA-002

2025-10-14T12:55:36.000Z - 8 months ago

Celularity announces publication of Phase 2 study on PDA-002


Celularity reports Q1 EPS (84c) vs ($1.03) last year

2025-09-03T12:10:50.000Z - 9 months ago

Celularity reports Q1 EPS (84c) vs ($1.03) last year


Celularity regains compliance with Nasdaq listing rule

2025-09-03T12:10:44.000Z - 9 months ago

Celularity regains compliance with Nasdaq listing rule


Celularity Quarterly report: Q2 2025

Aug 29, 2025, 9:30 AM EDT - 9 months ago

Celularity Quarterly report: Q2 2025


Celularity Quarterly report: Q1 2025

Aug 29, 2025, 12:00 AM EDT - 10 months ago

Celularity Quarterly report: Q1 2025


Celularity receives noncompliance notice from Nasdaq

2025-08-22T21:35:07.000Z - 10 months ago

Celularity receives noncompliance notice from Nasdaq


Celularity terminates CFO David Beers

2025-06-10T20:25:24.000Z - 1 year ago

Celularity terminates CFO David Beers


Celularity Announces Chief Financial Officer Transition

Jun 10, 2025, 4:15 PM EDT - 1 year ago

Celularity Announces Chief Financial Officer Transition


Celularity Earnings release: Q4 2024

May 9, 2025, 4:00 PM EDT - 1 year ago

Celularity Earnings release: Q4 2024


Celularity Annual report: Q4 2024

May 9, 2025, 4:00 PM EDT - 1 year ago

Celularity Annual report: Q4 2024


Celularity Registration statement: Registration Filing

Feb 13, 2025, 7:00 AM EST - 1 year ago

Celularity Registration statement: Registration Filing


Celularity Registration statement: Registration Filing

Jan 30, 2025, 7:00 AM EST - 1 year ago

Celularity Registration statement: Registration Filing


Celularity Quarterly report: Q3 2024

Dec 5, 2024, 6:00 PM EST - 1 year ago

Celularity Quarterly report: Q3 2024


Celularity Inc. Announces Receipt of Nasdaq Notification

Nov 27, 2024, 5:00 PM EST - 1 year ago

Celularity Inc. Announces Receipt of Nasdaq Notification


Celularity Proxy statement: Proxy Filing

Nov 19, 2024, 7:00 AM EST - 1 year ago

Celularity Proxy statement: Proxy Filing


Celularity Quarterly report: Q2 2024

Nov 6, 2024, 6:00 PM EST - 1 year ago

Celularity Quarterly report: Q2 2024


Celularity Quarterly report: Q1 2024

Oct 16, 2024, 3:30 AM EDT - 1 year ago

Celularity Quarterly report: Q1 2024


Celularity Annual report: Q4 2023

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Celularity Annual report: Q4 2023


Celularity Transcript: Analyst Research & Development Day 2024

May 21, 2024, 12:00 PM EDT - 2 years ago

Celularity Transcript: Analyst Research & Development Day 2024


Celularity Slides: FY 2024

May 21, 2024, 12:00 PM EDT - 2 years ago

Celularity Slides: FY 2024


luckydog2
luckydog2 Jun. 4 at 1:31 PM
$CELU @nosey could this be the reason Dr. Hariri was meeting with RFK?
1 · Reply
luckydog2
luckydog2 Jun. 4 at 12:03 PM
$CELU Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies https://www.globenewswire.com/news-release/2026/06/04/3306696/0/en/celularity-and-fountain-life-announce-availability-of-cenplacel-l-for-investigational-use-under-new-florida-law-establishing-scalable-pathway-for-advancement-of-placental-derived-c.html?_gl=1*llxv7e*_up*MQ..*_ga*NDUzMTIyMzA4LjE3ODA1NzQ0ODI.*_ga_B6167QB2TF*czE3ODA1NzQ0ODEkbzEkZzAkdDE3ODA1NzQ1MjkkajEyJGwwJGgzMDY4MTM5MTY.*_ga_ERWPGTJ5X8*czE3ODA1NzQ0ODEkbzEkZzAkdDE3ODA1NzQ1MjkkajEyJGwwJGgw
0 · Reply
Nosay
Nosay Jun. 4 at 10:16 AM
$CELU shareholder letter didn’t contain much. But I did appreciate that it said we can expect more future updates. I am hoping this is the start of the pump. No idea how high it will go. But the insiders own approx 75% and unlocked all of their shares in December and early Jan allowing them to sell on the open market. Their warrants repriced to 1.33 as well. Phil Barach has warrants at 1.66 and 2$. They need to raise more money at some point. They can easily drive this up much higher than that and exercise their warrants and sell for a profit. My bet is $8 ish. But we’ll see.
0 · Reply
focafoca99
focafoca99 Jun. 3 at 9:36 PM
$CELU promoted Rick Gonzalez to Chief Commercial Officer.
0 · Reply
KingStocks1
KingStocks1 Jun. 3 at 8:49 PM
$CELU piece of shit shareholder update form CEO. 5+ years of bullshit
0 · Reply
luckydog2
luckydog2 Jun. 3 at 8:33 PM
$CELU Dr. Hariri's letter to shareholders. https://www.reddit.com/r/CelularityNews/s/mrGN3bEeX3
0 · Reply
luckydog2
luckydog2 Jun. 3 at 12:15 PM
$CELU Celularity Appoints Rick Gonzalez as Chief Commercial Officer Appointment supports Celularity’s focus on longevity, regenerative medicine and preservation of human performance by advancing commercialization of cenplacel-L and Lifebank https://www.globenewswire.com/news-release/2026/06/03/3305991/0/en/celularity-appoints-rick-gonzalez-as-chief-commercial-officer.html?_gl=1*1fawbd*_up*MQ..*_ga*MTM4MTg4OTUyMy4xNzgwNDg4Nzg3*_ga_ERWPGTJ5X8*czE3ODA0ODg3ODckbzEkZzAkdDE3ODA0ODg3ODckajYwJGwwJGgw*_ga_B6167QB2TF*czE3ODA0ODg3ODckbzEkZzAkdDE3ODA0ODg3ODckajYwJGwwJGgxNTY3OTA1MTg4
0 · Reply
ToxicAvenger
ToxicAvenger Jun. 1 at 10:14 PM
$CELU almost boom time...
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Jun. 1 at 8:39 PM
$CELU Looks like shorts covering. Let go captain Harri
0 · Reply
Nosay
Nosay Jun. 1 at 6:34 PM
$IBRX $CELU if you would have listened to me this morning you’d be up 6% instead of down 4%. Should be a massive run up after filing Q1s regaining compliance and announcing the positive results seen from Fountain Life.
1 · Reply
Nosay
Nosay Jun. 1 at 11:46 AM
$IBRX a company which has a similar product offering and a massive upside is $CELU. Obviously not an FDA approved commercial product at this point. So they are left selling in a few states which are receptive to stem cell treatments like Florida, Utah, soon to be Arizona. But they are partnered with a facility in SE Asia opening this fall. They have a built in sales network with the Fountain Life network which is growing. And the CEO is known to have had recent meetings with RFK🫣 It is about 75% insider owned. Still Founder run. Ties to Tony Robbin’s (indirect through fountain life) and Peter Diamandis (sitting board member). When they decide they want to promote. Imagine what a tweet or podcast episode may do. Phil Barach became a 20% owner in December. His warrants are at 1.66 and 2.00. Almost double current price. At 1/200th of the market cap of IBRX it might be a gamble worth taking on a small position.
1 · Reply
luckydog2
luckydog2 May. 30 at 1:28 PM
$CELU Human Placental Derived Natural Killer Cells with High Affinity and Cleavage Resistant CD16 and Secreted IL-15 https://www.reddit.com/r/CelularityNews/s/ON0YL8pgcC
0 · Reply
KingStocks1
KingStocks1 May. 29 at 9:23 PM
$CELU another Nasdaq delisting warning for missing 1Q earnings. Fucking joke of a company. Someone please put them on blast on their LinkedIn posts to call them out, reverse split, multiple missed earnings, delist warning, zero update from CEO.
0 · Reply
FunCoupons00
FunCoupons00 May. 29 at 11:44 AM
$CELU I think this is coiled up & bound to go eventually… the longevity sector hasn’t made a move yet but when it does they will people will not know what hit them when it does…
1 · Reply
esb016
esb016 May. 29 at 3:12 AM
$CELU Hariri wake up. You have a company to run you have thousands of patents you have an incredible future but don't forget you also have stockholders. You need to tell us something positive be optimistic and pump it up.
0 · Reply
luckydog2
luckydog2 May. 28 at 9:42 PM
$CELU Helena default crisis avoided. https://www.reddit.com/r/CelularityNews/s/nc8XG5Yxu9
0 · Reply
KingStocks1
KingStocks1 May. 28 at 5:12 PM
$CELU sad that it’s slightly exciting to see it climb above $1 after years of torture… not sure how they can pump this
0 · Reply
KingStocks1
KingStocks1 May. 27 at 3:34 PM
$CELU we’ve been saying this shit for a few years now. They’re looking more and more like bankruptcy/reverse split again. Zero transparency from board or ceo for over a year now. Just major cash burn and liquidity issues. Us few retailers left are so frustrated and confused how we can ever get another pump with what’s remaining. Disappointed
0 · Reply
Nosay
Nosay May. 27 at 2:48 PM
$CELU We’re flirting with a good day and nobody cares. They’ve shaken out retail almost entirely. 75% insider owned. Probably about to 🚀now that no one is watching.
1 · Reply
topstockalerts
topstockalerts May. 20 at 11:34 PM
After Hours Top Gainers PT2 $UCAR $WOK $BNZI $ILLR $CELU
0 · Reply
luckydog2
luckydog2 May. 20 at 5:59 PM
$CELU Retrospective Evaluation of Successive Biovance® Decellularized Basement Membrane Tissue Grafts for the Management of Chronic Subclinical and Stage 1 Neurotrophic Keratitis https://www.reddit.com/r/CelularityNews/s/IDM2cougSL
0 · Reply
esb016
esb016 May. 18 at 8:31 AM
$CELU Harami Hariri. Wake up.
1 · Reply